Q2 FY2026 EarningsQ2 FY26 results significantly beat consensus across all key profitability metrics, driven by a 46% YoY surge in effectuated membership to 3.0 million. Revenue reached $4.88B, slightly exceeding the $4.75B estimate, while GAAP EPS of $1.10 crushed the $0.35 mean expectation. The MLR improved remarkably to 79.2% (vs. 91.1% YoY) due to disciplined pricing and favorable reserve development, significantly outperforming the implied consensus gross margin level.
Financial report interval: 2026.03.30 - 2026.06.30
Overview: Oscar Health(OSCR) the Revenue is 4.88 B (+70.4%), Beat estimate;the EBIT is 388.64 M (+268.6%), Beat estimate;the EPS is 1.1 (+223.6%), Beat estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueExceed expectations
4.88B70.40%
4.75B65.89%
+0.13B4.51%
EBITExceed expectations
0.39B268.62%
0.15B163.43%
+0.24B105.19%
EPSExceed expectations
1.1223.60%
0.3526139.61%
+0.747483.99%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf